Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-19 | 2024-05-31 | 216690 |
| APO-QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-19 | 2024-11-14 | 216693 |
| APO-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-19 | 2024-07-18 | 216696 |
| APO-QUINAPRIL | 10MG | TABLET | Resolved | 2017-03-11 | 2017-05-02 | 453 |
| APO-QUINAPRIL | 10MG | TABLET | Resolved | 2017-03-11 | 2017-06-05 | 463 |
| APO-QUINAPRIL | 10MG | TABLET | Resolved | 2017-07-26 | 2017-10-18 | 17315 |
| APO-QUINAPRIL | 5MG | TABLET | Resolved | 2018-01-31 | 2018-05-25 | 37740 |
| APO-QUINAPRIL | 10MG | TABLET | Resolved | 2018-02-26 | 2018-05-25 | 41139 |
| APO-QUINAPRIL | 20MG | TABLET | Resolved | 2018-03-05 | 2018-05-25 | 41865 |
| APO-QUINAPRIL | 20MG | TABLET | Resolved | 2018-08-09 | 2019-05-13 | 57805 |
| APO-QUINAPRIL | 40MG | TABLET | Resolved | 2018-08-09 | 2019-05-21 | 57808 |
| APO-QUINAPRIL | 5MG | TABLET | Resolved | 2018-11-09 | 2019-05-21 | 66623 |
| APO-QUINAPRIL | 10MG | TABLET | Resolved | 2018-11-09 | 2019-05-21 | 66626 |
| APO-QUINAPRIL | 10MG | TABLET | Resolved | 2020-02-13 | 2020-06-22 | 106056 |
| APO-QUINAPRIL | 20MG | TABLET | Resolved | 2020-04-13 | 2020-06-22 | 111951 |
| APO-QUINAPRIL | 5MG | TABLET | Actual shortage | 2021-03-15 | 2021-10-29 | 135685 |
| APO-QUINAPRIL | 10MG | TABLET | Actual shortage | 2021-03-15 | 2021-10-29 | 135689 |
| APO-QUINAPRIL | 20MG | TABLET | Actual shortage | 2021-03-15 | 2021-12-03 | 135692 |
| APO-QUINAPRIL | 40MG | TABLET | Actual shortage | 2021-03-15 | 2021-10-30 | 135695 |
| APO-QUINAPRIL/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2017-09-04 | 2018-04-15 | 20891 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |